Dongkook Pharmaceutical
Corée du Sud
sponsorship_level.classic+
Site web: https://dkpharm.co.kr/en
Marques : Bellast Prime™, Madechiel™
Numéro de stand : P225
Catégorie
- Injectables: Produits de comblement
- Médicaments - Produits pharmaceutiques
- Cosmeceutics - Produits anti-âge
Profil de l'entreprise
Dongkook Pharmaceutical is a leading Korean pharmaceutical company committed to improving quality of life through science-driven innovation and pharmaceutical excellence.
Guided by our philosophy, "Our Passion, Your Health," we develop safe, reliable, and clinically focused aesthetic solutions that support both physicians and patients.
Our aesthetic portfolio includes Bellast Prime, a premium hyaluronic acid dermal filler designed for precise volumization and natural-looking outcomes, and Madechiel™, an advanced topical skin booster developed with soluble chitosan technology to help support skin conditioning and post-procedure recovery.
At IMCAS, we look forward to collaborating with global partners who share our commitment to innovation, quality, and evidence-based medical aesthetics.
Guided by our philosophy, "Our Passion, Your Health," we develop safe, reliable, and clinically focused aesthetic solutions that support both physicians and patients.
Our aesthetic portfolio includes Bellast Prime, a premium hyaluronic acid dermal filler designed for precise volumization and natural-looking outcomes, and Madechiel™, an advanced topical skin booster developed with soluble chitosan technology to help support skin conditioning and post-procedure recovery.
At IMCAS, we look forward to collaborating with global partners who share our commitment to innovation, quality, and evidence-based medical aesthetics.